PeptiDream Inc. (PPTDF) Discusses Progress in Radiopharmaceuticals and Peptide Therapeutics Pipeline Transcript

Group 1 - PeptiDream held its 2025 R&D Day Conference Call to provide updates on research and development programs [1][2] - Key executives present included the CEO, Chief Medical Officer, and Chief Scientific Officer [1] - The call included forward-looking statements regarding PeptiDream's future expectations and plans [2]